Postdoctoral Research Associate in NLRPInflammasome and Tumour Immune Evasion
-
Research/Development
Job Description & How to Apply Below
University of North Carolina at Chapel Hill
· Lineberger Comprehensive Cancer Center
United States
30 November 2026 (date-only; no cutoff time specified)
About This Opportunity
UNC Lineberger Cancer Center seeks a postdoctoral researcher to investigate tumour-intrinsic NLRP3, immune evasion and therapy-resistant tumour persistence using co-cultures, mouse models and molecular assays in Chapel Hill.
This postdoctoral research appointment at the University of North Carolina at Chapel Hill's Lineberger Comprehensive Cancer Center investigates how the tumour-intrinsic NLRP3 inflammasome may contribute to immune evasion during tumour dormancy, therapy-resistant persister-cell development, relapse and metastatic progression. Its central research aim is to connect inflammasome-associated tumour biology with interactions between tumour cells and the immune system during persistence and recurrence.
The research uses ex vivo tumour–T-cell co-culture systems, in vivo tumour models and clinical tumour specimens. Advertised methods include targeted CRISPR/Cas9 gene deletion, microbead and FACS-based cell purification, flow cytometry, Western blotting, quantitative RT-PCR, ELISA, bulk RNA sequencing, single-cell RNA sequencing, micro-CT imaging, immunohistochemistry, FISH and proximity ligation assays. Spatial transcriptomics may also form part of the work. The list describes tools anticipated for the project;
the employer differentiates core past experience from preferred RNA-sequencing and CRISPR preparation.
An earned PhD is mandatory. Candidates are expected to have experience with mouse tumour models and tissue-culture experiments and familiarity with flow cytometry and immunohistochemistry. Prior work collecting or analysing RNA-sequencing data and using CRISPR/Cas9 is preferred. This is a full-time temporary position (40 hours per week) at Chapel Hill, initially estimated at 12 months. Salary is determined by experience and qualifications, with no numerical amount advertised.
The Final date to receive applications is 30 November 2026; the official listing does not specify an exact cutoff hour.
Who This Opportunity Is Best Suited For:
Based on the advertised experiments, the strongest fit is likely to be a recent doctoral graduate in cancer biology, tumour immunology, molecular biology or a related biomedical field with hands-on mouse-tumour and mammalian cell-culture experience. Researchers who have combined immune-cell phenotyping with tissue pathology or gene perturbation, especially in resistance and metastatic disease, may be particularly prepared for the work. RNA-seq and CRISPR experience would add a relevant advantage rather than being presented as universal minimum requirements.
Potential Challenges / Who May Find It Less Suitable:
This appointment depends on substantial wet-laboratory expertise, animal tumour models and access to clinical specimens; it is not primarily a desk-based computational research role. A PhD and the stated mouse-model, tissue-culture, flow-cytometry and immunohistochemistry background are important prerequisites. The contract is estimated at one year, while compensation details are individualised rather than stated numerically.
Overall Opportunity Assessment:
The distinguishing feature is the mechanistic link between NLRP3-mediated immune evasion and tumour persistence, investigated through a broad experimental toolkit from co-culture and animal models to single-cell and tissue-level assays. Researchers seeking translational tumour immunology should weigh the demanding experimental background and short fixed-term structure.
NLRP3 inflammasome immune evasion tumour dormancy therapy resistance tumour relapse tumour immunology
Level Postdoc
Time Commitment Full-time
Duration 12 months estimated
Reference Code PDS
004903
Field Cancer Biology
Organization Type University
Funding & Compensation
Amount Paid
Funding Type Salary
Funding Status Paid
Requirements
Education
Completed PhD required.
Experience
Prior mouse tumour-model and tissue-culture studies, flow cytometry and immunohistochemistry required; RNA-seq and CRISPR/Cas9 experience preferred.
Technical Skills
- Mouse tumour models
- Mouse tumour–T-cell co-cultures
- Flow cytometry
- Immunohistochemistry
- CRISPR/Cas9 (preferred)
- RNA sequencing (preferred)
- Single-cell RNA sequencing
- Western blotting
- FACS purification
General Skills
- Experimental cancer research
- Laboratory data analysis
Position Requirements
10+ Years work experience(If this job is in fact in your jurisdiction, then you may be using a Proxy or VPN to access this site, and to progress further, you should change your connectivity to another mobile device or PC).
View / Apply for Jobs
Matching My Jurisdiction